The Fund seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary.
| Classification | Inception Date | Primary Exchange |
|---|---|---|
| Health/Biotech Funds | 10/31/2014 | Cboe BZX |
Investment Information
| Market Cap | 3.81B |
| Net Assets | 5.06B |
| NAV | 47.81 |
| Shares Outstanding | 81.66M |
| Avg Daily Vol | 4.07M |
| Dividend Yield | 0.00% |
| Dividend | 0.38 |
| Ex Dividend Date | 12/29/21 |
Detailed Information
| Mgmt Co | ARK Invest |
| Turnover | 45.00% |
| Beta | 1.24 |
| P/E | 18.83 |
| P/B | 5.61 |
| Expense Ratio | 0.75% |
To receive a prospectus
ARK Invest3 E 28th Street
7th Floor
New York, NY 10016
Performance
| ARKG | S&P 500 TR IX | |
|---|---|---|
| 1 week | -6.50 | -3.77 |
| 4 weeks | -24.97 | -5.06 |
| 3 months | -36.20 | -1.14 |
| 1 year | -57.00 | 18.03 |
| 3 years | 20.37 | 20.89 |
| 5 years | 24.80 | 16.69 |
